Capital Markets: Derivatives & Structured Products (International Firms) | Greater China Region

Linklaters' deeply resourced structured finance and derivatives team boasts a strong bench advising on margin loans and QFII structures and is hugely influential in the OTC derivatives market. A prominent practice advising on regulatory developments pertaining to OTC clearing and exchange trading, it is also highly commended for its standout securitisation practice, which is most notably active in China and is a first port of call for advice on regulatory development. The team is active on cross-border loan repackaging and the issuance of repackaged notes, as well as advising on covered bonds. It commonly acts for relevant regulators, financial institutions and SOEs. Clients benefit from the firm's joint operation with Zhao Sheng Law Firm.

A&O Shearman offers a hugely respected Hong Kong-based team advising on a range of complex and novel cross-border transactions, including structured credit and structured equity matters. The team is also highly active in advising on margin finance, syndicated loans and bond repackaging matters, and very experienced in advising on OTC derivatives regulations, with particular expertise in issues relating to the implementation of the European Market Infrastructure Regulation. The team is also well versed in credit default and total return swap structures, as well as collar financing. It continues to have strong relationships with regulators, including the ISDA. The firm advises an enviable list of leading international banks, as well as Chinese corporates and funds.

Ashurst boasts a solid structured finance and derivatives team which advises on OTC derivatives and CLNs among other products across the Asia-Pacific region, regularly drawing on the strengths of its regional offices to offer clients solutions to cross-border issues. Its expertise spans synthetic note issuances, mini-future warrants, total return swaps and credit default swaps. The team is well versed in assisting with large-scale repackaging programmes and frequently acts on behalf of international banks and Chinese asset management companies.

King & Wood Mallesons offers a strong securitisation practice, frequently acting for major clients on novel and complicated cross-border issuances, including international securitisation of PRC assets. It is also known for its robust derivatives and structured products expertise, advising clients on regulatory and transactional matters, including OTC derivatives transactions for both buyers and sellers. The team is noted for a particularly deep well of expertise relating to warrants. Clients benefit from its very strong Mainland China network and its pool of Australian experience. The team is frequently engaged by regulatory bodies, as well as Hong Kong and PRC securities firms and fund houses.

Latham & Watkins' robust structured products team advises banks in the OTC derivatives space, with expertise encompassing futures, options and swaps. The team is also highlighted for impressive structured equity and margin finance expertise, offering expertise on share forward transactions and collar transactions.

Clifford Chance's Hong Kong-based derivatives and structured products team stands out for its work on regulatory developments, especially in relation to derivatives reform and legislation across the Asia-Pacific region, including the liberalisation of the Chinese markets. The team is highly knowledgeable regarding exchange-traded and OTC derivatives issues and is particularly noted for structured credit transactions and collar option financing. It is sought after by both international and domestic investment banks, private equity sponsors and funds.

CMS offers deep expertise in both derivatives and structured products and securitisation mandates. The team is frequently called on to handle derivatives restructuring, structured financing, as well as advising on various asset and mortgage-backed securitisation matters.